MapLight Therapeutics

MPLTNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$402.244 M

$6.21 -7.45%

Close of 6 Nov 2026

As of 6 Nov 2026, MapLight Therapeutics (MPLT) has a market capitalization of $402.2M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

—

Not reported

Earnings

-$161.2M

Loss-making

Shares outstanding

42,436,326

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →

#203Prothena Corp PublicPRTA$406.3M
#204Relmada TherapeuticsRLMD$402.7M
#205MapLight TherapeuticsMPLT$402.2M
#206Assembly BiosciencesASMB$401.7M
#207KamadaKMDA$397.0M

Insiders buying

All insider buying →

3 open-market purchases by officers and directors of MapLight Therapeutics, worth $65.5M. Grants and option exercises are excluded.

Catalyst4, Inc.$50.1M
4,400,000 shares at $11.38 on 14 Aug 2026 · filed 18 Aug 2026
Catalyst4, Inc.$15.3M
1,209,225 shares at $12.66 on 28 Jul 2026 · filed 30 Jul 2026
Troy Cox$148.7K
15,620 shares at $9.52 on 28 Jul 2026 · filed 28 Jul 2026

What if MapLight Therapeutics were worth as much as…

Open the what-if tool →

Gold $28.2T

$435,931.79

Per share 70,198× higher

Bitcoin $1.53T

$23,587.51

Per share 3,798× higher

Apple $5.02T

$77,435.59

Per share 12,469× higher

Or at a round number

$500.0M $1.00B $2.00B $5.00B

Where these numbers come from

Share counts and financials for MapLight Therapeutics are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.